Int J Pediatr Otorhinolaryngol:腺样体肥大对渗出性中耳炎儿童患者听力阈值的影响研究

2019-06-19 AlexYang MedSci原创

渗出性中耳炎是一种常见的中耳粘膜疾病,能够引起儿童听力损失。腺样体肥大除了引起渗出性中耳炎之外,还能够引起复发性急性中耳炎。最近,有研究人员调查了腺样体肥大对渗出性中耳炎儿童患者听力阈值的影响。研究包括了50名年龄在5-15岁的儿童,共88只耳朵。在500?Hz、1000?Hz和2000?Hz时平均空气传导阈值均值在腺样体组织大小分组1-4组中分别为22?dB HL、20?dB HL、15?dB

渗出性中耳炎是一种常见的中耳粘膜疾病,能够引起儿童听力损失。腺样体肥大除了引起渗出性中耳炎之外,还能够引起复发性急性中耳炎。最近,有研究人员调查了腺样体肥大对渗出性中耳炎儿童患者听力阈值的影响。

研究包括了50名年龄在5-15岁的儿童,共88只耳朵。在500Hz、1000Hz和2000Hz时平均空气传导阈值均值在腺样体组织大小分组1-4组中分别为22dB HL、20dB HL、15dB HL和20dB HL。在腺样体定位组A-C组中,平均空气传导阈值分别为 20dB HL、20dBHL和18dB HL。研究人员在小组(p:0.213)和相关听力值(p:0.670)之间没有发现明显的相关性,且在46只耳朵中鉴定出了B型鼓室导抗图 ,在42只耳朵中鉴定了C型鼓室导抗图。平均听力阈值在渗出性中耳炎案例的B型鼓室导抗图中显著更高(P<0.001)。另外,研究人员没有发现益处持续的时间和腺样体大小(p:0.931)、腺样体定位(p:0.626)和听力阈值(p:0.815)之间的相关性。

最后,研究人员指出,渗出性中耳炎患者中腺样体大小和定位对听力阈值和溢出时间没有影响,并且渗出性中耳炎案例中应当慎重决定进行腺样体切除手术。另外,腺样体切除术不应当在大于4岁的儿童中进行,除非有确定的鼻塞或者慢性腺炎证据。

原始出处:


本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1728022, encodeId=00721e2802214, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Aug 14 15:53:00 CST 2019, time=2019-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2079976, encodeId=b42220e997623, content=<a href='/topic/show?id=38b685e0729' target=_blank style='color:#2F92EE;'>#腺样体肥大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85707, encryptionId=38b685e0729, topicName=腺样体肥大)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=362b271, createdName=zexyw01, createdTime=Sat Feb 15 06:53:00 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639153, encodeId=69bc163915339, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Jan 01 01:53:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306387, encodeId=6ff9130638e65, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Fri Jun 21 03:53:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344507, encodeId=3261134450e96, content=<a href='/topic/show?id=a01b2239e0b' target=_blank style='color:#2F92EE;'>#中耳炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22397, encryptionId=a01b2239e0b, topicName=中耳炎)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/vLodSSFTQLpHtfwJicWJibSWH7pbiauxvpCMvQIv0N9Oes8vHkDkCIW2HNDkt7icUq3RCZiaDcHR9Rap17fFySRbiaFg/132, createdBy=9f202500205, createdName=ms3297076796458174, createdTime=Fri Jun 21 03:53:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534935, encodeId=ccd01534935e1, content=<a href='/topic/show?id=cd9c392e372' target=_blank style='color:#2F92EE;'>#听力阈值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39273, encryptionId=cd9c392e372, topicName=听力阈值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c2112566955, createdName=aliceclz, createdTime=Fri Jun 21 03:53:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553611, encodeId=8ee31553611f9, content=<a href='/topic/show?id=839e9e33475' target=_blank style='color:#2F92EE;'>#阈值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97334, encryptionId=839e9e33475, topicName=阈值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f4f14387940, createdName=qjddjq, createdTime=Fri Jun 21 03:53:00 CST 2019, time=2019-06-21, status=1, ipAttribution=)]
    2019-08-14 feather89
  2. [GetPortalCommentsPageByObjectIdResponse(id=1728022, encodeId=00721e2802214, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Aug 14 15:53:00 CST 2019, time=2019-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2079976, encodeId=b42220e997623, content=<a href='/topic/show?id=38b685e0729' target=_blank style='color:#2F92EE;'>#腺样体肥大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85707, encryptionId=38b685e0729, topicName=腺样体肥大)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=362b271, createdName=zexyw01, createdTime=Sat Feb 15 06:53:00 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639153, encodeId=69bc163915339, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Jan 01 01:53:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306387, encodeId=6ff9130638e65, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Fri Jun 21 03:53:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344507, encodeId=3261134450e96, content=<a href='/topic/show?id=a01b2239e0b' target=_blank style='color:#2F92EE;'>#中耳炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22397, encryptionId=a01b2239e0b, topicName=中耳炎)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/vLodSSFTQLpHtfwJicWJibSWH7pbiauxvpCMvQIv0N9Oes8vHkDkCIW2HNDkt7icUq3RCZiaDcHR9Rap17fFySRbiaFg/132, createdBy=9f202500205, createdName=ms3297076796458174, createdTime=Fri Jun 21 03:53:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534935, encodeId=ccd01534935e1, content=<a href='/topic/show?id=cd9c392e372' target=_blank style='color:#2F92EE;'>#听力阈值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39273, encryptionId=cd9c392e372, topicName=听力阈值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c2112566955, createdName=aliceclz, createdTime=Fri Jun 21 03:53:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553611, encodeId=8ee31553611f9, content=<a href='/topic/show?id=839e9e33475' target=_blank style='color:#2F92EE;'>#阈值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97334, encryptionId=839e9e33475, topicName=阈值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f4f14387940, createdName=qjddjq, createdTime=Fri Jun 21 03:53:00 CST 2019, time=2019-06-21, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1728022, encodeId=00721e2802214, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Aug 14 15:53:00 CST 2019, time=2019-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2079976, encodeId=b42220e997623, content=<a href='/topic/show?id=38b685e0729' target=_blank style='color:#2F92EE;'>#腺样体肥大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85707, encryptionId=38b685e0729, topicName=腺样体肥大)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=362b271, createdName=zexyw01, createdTime=Sat Feb 15 06:53:00 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639153, encodeId=69bc163915339, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Jan 01 01:53:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306387, encodeId=6ff9130638e65, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Fri Jun 21 03:53:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344507, encodeId=3261134450e96, content=<a href='/topic/show?id=a01b2239e0b' target=_blank style='color:#2F92EE;'>#中耳炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22397, encryptionId=a01b2239e0b, topicName=中耳炎)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/vLodSSFTQLpHtfwJicWJibSWH7pbiauxvpCMvQIv0N9Oes8vHkDkCIW2HNDkt7icUq3RCZiaDcHR9Rap17fFySRbiaFg/132, createdBy=9f202500205, createdName=ms3297076796458174, createdTime=Fri Jun 21 03:53:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534935, encodeId=ccd01534935e1, content=<a href='/topic/show?id=cd9c392e372' target=_blank style='color:#2F92EE;'>#听力阈值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39273, encryptionId=cd9c392e372, topicName=听力阈值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c2112566955, createdName=aliceclz, createdTime=Fri Jun 21 03:53:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553611, encodeId=8ee31553611f9, content=<a href='/topic/show?id=839e9e33475' target=_blank style='color:#2F92EE;'>#阈值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97334, encryptionId=839e9e33475, topicName=阈值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f4f14387940, createdName=qjddjq, createdTime=Fri Jun 21 03:53:00 CST 2019, time=2019-06-21, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1728022, encodeId=00721e2802214, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Aug 14 15:53:00 CST 2019, time=2019-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2079976, encodeId=b42220e997623, content=<a href='/topic/show?id=38b685e0729' target=_blank style='color:#2F92EE;'>#腺样体肥大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85707, encryptionId=38b685e0729, topicName=腺样体肥大)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=362b271, createdName=zexyw01, createdTime=Sat Feb 15 06:53:00 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639153, encodeId=69bc163915339, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Jan 01 01:53:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306387, encodeId=6ff9130638e65, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Fri Jun 21 03:53:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344507, encodeId=3261134450e96, content=<a href='/topic/show?id=a01b2239e0b' target=_blank style='color:#2F92EE;'>#中耳炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22397, encryptionId=a01b2239e0b, topicName=中耳炎)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/vLodSSFTQLpHtfwJicWJibSWH7pbiauxvpCMvQIv0N9Oes8vHkDkCIW2HNDkt7icUq3RCZiaDcHR9Rap17fFySRbiaFg/132, createdBy=9f202500205, createdName=ms3297076796458174, createdTime=Fri Jun 21 03:53:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534935, encodeId=ccd01534935e1, content=<a href='/topic/show?id=cd9c392e372' target=_blank style='color:#2F92EE;'>#听力阈值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39273, encryptionId=cd9c392e372, topicName=听力阈值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c2112566955, createdName=aliceclz, createdTime=Fri Jun 21 03:53:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553611, encodeId=8ee31553611f9, content=<a href='/topic/show?id=839e9e33475' target=_blank style='color:#2F92EE;'>#阈值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97334, encryptionId=839e9e33475, topicName=阈值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f4f14387940, createdName=qjddjq, createdTime=Fri Jun 21 03:53:00 CST 2019, time=2019-06-21, status=1, ipAttribution=)]
    2019-06-21 ysjykql
  5. [GetPortalCommentsPageByObjectIdResponse(id=1728022, encodeId=00721e2802214, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Aug 14 15:53:00 CST 2019, time=2019-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2079976, encodeId=b42220e997623, content=<a href='/topic/show?id=38b685e0729' target=_blank style='color:#2F92EE;'>#腺样体肥大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85707, encryptionId=38b685e0729, topicName=腺样体肥大)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=362b271, createdName=zexyw01, createdTime=Sat Feb 15 06:53:00 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639153, encodeId=69bc163915339, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Jan 01 01:53:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306387, encodeId=6ff9130638e65, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Fri Jun 21 03:53:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344507, encodeId=3261134450e96, content=<a href='/topic/show?id=a01b2239e0b' target=_blank style='color:#2F92EE;'>#中耳炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22397, encryptionId=a01b2239e0b, topicName=中耳炎)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/vLodSSFTQLpHtfwJicWJibSWH7pbiauxvpCMvQIv0N9Oes8vHkDkCIW2HNDkt7icUq3RCZiaDcHR9Rap17fFySRbiaFg/132, createdBy=9f202500205, createdName=ms3297076796458174, createdTime=Fri Jun 21 03:53:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534935, encodeId=ccd01534935e1, content=<a href='/topic/show?id=cd9c392e372' target=_blank style='color:#2F92EE;'>#听力阈值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39273, encryptionId=cd9c392e372, topicName=听力阈值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c2112566955, createdName=aliceclz, createdTime=Fri Jun 21 03:53:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553611, encodeId=8ee31553611f9, content=<a href='/topic/show?id=839e9e33475' target=_blank style='color:#2F92EE;'>#阈值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97334, encryptionId=839e9e33475, topicName=阈值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f4f14387940, createdName=qjddjq, createdTime=Fri Jun 21 03:53:00 CST 2019, time=2019-06-21, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1728022, encodeId=00721e2802214, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Aug 14 15:53:00 CST 2019, time=2019-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2079976, encodeId=b42220e997623, content=<a href='/topic/show?id=38b685e0729' target=_blank style='color:#2F92EE;'>#腺样体肥大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85707, encryptionId=38b685e0729, topicName=腺样体肥大)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=362b271, createdName=zexyw01, createdTime=Sat Feb 15 06:53:00 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639153, encodeId=69bc163915339, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Jan 01 01:53:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306387, encodeId=6ff9130638e65, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Fri Jun 21 03:53:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344507, encodeId=3261134450e96, content=<a href='/topic/show?id=a01b2239e0b' target=_blank style='color:#2F92EE;'>#中耳炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22397, encryptionId=a01b2239e0b, topicName=中耳炎)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/vLodSSFTQLpHtfwJicWJibSWH7pbiauxvpCMvQIv0N9Oes8vHkDkCIW2HNDkt7icUq3RCZiaDcHR9Rap17fFySRbiaFg/132, createdBy=9f202500205, createdName=ms3297076796458174, createdTime=Fri Jun 21 03:53:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534935, encodeId=ccd01534935e1, content=<a href='/topic/show?id=cd9c392e372' target=_blank style='color:#2F92EE;'>#听力阈值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39273, encryptionId=cd9c392e372, topicName=听力阈值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c2112566955, createdName=aliceclz, createdTime=Fri Jun 21 03:53:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553611, encodeId=8ee31553611f9, content=<a href='/topic/show?id=839e9e33475' target=_blank style='color:#2F92EE;'>#阈值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97334, encryptionId=839e9e33475, topicName=阈值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f4f14387940, createdName=qjddjq, createdTime=Fri Jun 21 03:53:00 CST 2019, time=2019-06-21, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1728022, encodeId=00721e2802214, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Aug 14 15:53:00 CST 2019, time=2019-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2079976, encodeId=b42220e997623, content=<a href='/topic/show?id=38b685e0729' target=_blank style='color:#2F92EE;'>#腺样体肥大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85707, encryptionId=38b685e0729, topicName=腺样体肥大)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=362b271, createdName=zexyw01, createdTime=Sat Feb 15 06:53:00 CST 2020, time=2020-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639153, encodeId=69bc163915339, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Jan 01 01:53:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306387, encodeId=6ff9130638e65, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Fri Jun 21 03:53:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344507, encodeId=3261134450e96, content=<a href='/topic/show?id=a01b2239e0b' target=_blank style='color:#2F92EE;'>#中耳炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22397, encryptionId=a01b2239e0b, topicName=中耳炎)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/vLodSSFTQLpHtfwJicWJibSWH7pbiauxvpCMvQIv0N9Oes8vHkDkCIW2HNDkt7icUq3RCZiaDcHR9Rap17fFySRbiaFg/132, createdBy=9f202500205, createdName=ms3297076796458174, createdTime=Fri Jun 21 03:53:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534935, encodeId=ccd01534935e1, content=<a href='/topic/show?id=cd9c392e372' target=_blank style='color:#2F92EE;'>#听力阈值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39273, encryptionId=cd9c392e372, topicName=听力阈值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c2112566955, createdName=aliceclz, createdTime=Fri Jun 21 03:53:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553611, encodeId=8ee31553611f9, content=<a href='/topic/show?id=839e9e33475' target=_blank style='color:#2F92EE;'>#阈值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97334, encryptionId=839e9e33475, topicName=阈值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f4f14387940, createdName=qjddjq, createdTime=Fri Jun 21 03:53:00 CST 2019, time=2019-06-21, status=1, ipAttribution=)]
    2019-06-21 qjddjq

相关资讯

Laryngoscope:鼓膜穿孔患者中听力损失与中耳容积关系研究

最近,有研究人员调查了由鼓膜(TM)穿孔引起的传导性听力损失(CHL)程度与乳突-中耳体积之间的关系。研究人员招募了2010年到2018年之间的那些诊断为TM穿孔的患者,并且收集了他们的听力测定数据。根据来源自患者头部或颞骨CT的分割分析推算了患者的乳突-中耳容积(MMEV),之后,研究人员将推算的MMEV与来源于鼓室导抗测试的MMEV数据进行了比较。研究发现,来源自患者头部或颞骨CT的分割分析的

JAMA Otolaryngol Head Neck Surg:听力阈值提高群体中自我报道良好听力的流行度和特征研究

听力损失的听觉测定证据并不总与自我报道的听力损失有关。最近,有研究人员确定了自我报道良好听力在一个听力测定定义为听力损失患者群体中的比例并鉴定了相关因子。研究发现,任何频率下>25dB HL的平均(SD)年龄为47.0(0.4),而PTA>25dB HL的平均年龄为52.5(1.1)。对于那些通过任何频率下>25dB定义的HL群体,744(56.1%)名为男性,629(43.9%

Int J Dev Neurosci:感觉神经性听力损失患者的左枕外侧皮质厚度减少

感觉神经性听力损失患者(SNHL)倾向于表现出语言发育延迟、执行功能缺陷和视觉认知障碍,甚至是听力扩大和耳蜗移植介入之后,仍旧表现出上述情况,表明了SNHL患者中大脑结构和功能已经发生了改变。最近,有研究人员调查了30名SNHL儿童中大脑MRI结构情况(18名轻度到中度SNHL(M-M),12名重度到永久性SNHL(M-P)),并与性别和年龄相匹配的正常对照(NC)进行了比较。研究发现,区域分析表

老年听力损失诊断与干预专家共识

随着老龄化的到来,老年听力损失越来越成为一个社会问题。我国现阶段的儿童听力康复成绩可圈可点,但对老年群体的听力康复关注度远远不够。

Int J Pediatr Otorhinolaryngol:母亲和孕妇对儿童听力损失的认知和态度调查

母亲对儿童听力损失的认知和态度在决定儿童听力损失早期诊断和干预方面具有重要的作用。最近,有研究人员评估了母亲对儿童听力损失的认知和态度,比较了城市和乡村母亲对儿童听力损失的认知和态度,并调查了认知和态度之间的相关性以及见顶了能够影响目前对儿童听力损失认知和态度的社会人口因素。研究是一个代表性的研究,包括了362名母亲和孕妇(平均年龄为31.9±4.9,范围为20-48岁)。研究发现,大多数木器对儿

Aging (Albany NY):年龄相关的听力损失能够促进脑脊液tau水平和脑萎缩

年龄相关的听力损失(ARHL)被认为是认识损伤和痴呆的一种有希望改变的风险因子。尽管如此,是否年龄相关的听力损失与老年痴呆症(AD)的神经退行性生物标志物相关仍旧不清楚。最近,有研究人员在ADNI数据库中选择了ARHL的患者的数据。研究人员在多变量模型中,探索了ARHL与CSF β-淀粉样蛋白(Aβ)和tau测量值、脑部Aβ负载和皮质结构测量之间的相关性。研究发现,ARHL与更高的tau CSF水